Financial Results for the quarter and financial year ended 31st March 2026

Exceptional ItemPat NegativeResults View source PDF Explain this filing

BAJAJHCARE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-10.5%Reaction day

₹338.45

prior close

₹300.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.4%-9.1% vs market

Pharmaceuticals peers, median of 158sector-0.4%-10.1% vs sector

On the reaction day the stock moved 9.1 pts less than Nifty Microcap 250 and 10.1 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+3.0

10m

+4.5

15m

+5.3

30m

+4.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-10.5-1.4-9.1-0.4-10.1

Next day

-12.8-4.5-8.4-1.9-10.9

-12.5-3.8-8.7-2.6-10.0

-12.8-3.6-9.3-2.1-10.8

-16.4-3.9-12.5-2.0-14.4

-18.7-5.2-13.5-2.6-16.2

-10.5-4.2-6.3-1.5-9.0

15d

-11.9-1.5-10.4-1.8-10.1

-16.7-3.1-13.6-1.3-15.4

+1.7+6.4-4.7+4.2-2.5

-3.0+8.3-11.3+6.3-9.3

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 158Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Bajaj Healthcare reported FY26 revenue of Rs 6,110.3 crore, up 12.6% from Rs 5,426.0 crore in FY25, showing steady topline growth. However, profit after tax dropped significantly to Rs 157.7 lakh (continuing operations: Rs 213.1 lakh) versus Rs 395.0 lakh in FY25, a decline of approximately 60%. The sharp profit decline was primarily due to a Rs 332.5 crore exceptional charge from reversing technical know-how income from a Middle East customer arrangement affected by regional instability. Without this exceptional item, operating profit before tax was Rs 621.7 crore, up 35% year-on-year. The company also completed warrant conversion, raising Rs 5,271 lakh, and recommended a 30% dividend (Rs 1.50 per share).

Likely market impact

The stock may face near-term pressure due to the 60% PAT decline, but underlying business remains profitable with 35% operating profit growth excluding the one-time exceptional charge. The Middle East-related income reversal signals execution risk in international technical know-how agreements.